Karyopharm Therapeutics Inc. Accounts Payable
Karyopharm Therapeutics Inc. (KPTI) had Accounts Payable of $7.66 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $7.66M.
- 2026-03-31: Accounts Payable, Current $4.28M.
- 2025-12-31: Accounts Payable, Current $4.00M.
- 2025-09-30: Accounts Payable, Current $5.39M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $7.66M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $4.28M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $4.00M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $5.39M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $2.60M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $5.87M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $5.11M 10-K · filed 2026-02-13 |
| 2024-09-30 | $5.78M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $2.80M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $5.03M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $3.12M 10-K · filed 2025-02-19 |
| 2023-09-30 | $943.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $2.29M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $9.04M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $2.77M 10-K · filed 2024-02-29 |
| 2022-09-30 | $813.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.69M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.44M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.60M 10-K · filed 2023-02-17 |
| 2021-09-30 | $881.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $2.31M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $3.04M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $4.45M 10-K · filed 2022-03-01 |
| 2020-09-30 | $2.42M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $1.89M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $1.69M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $985.00K 10-K · filed 2021-02-24 |
| 2019-09-30 | $3.07M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $1.11M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $2.27M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $4.33M 10-K · filed 2020-02-26 |
| 2018-09-30 | $2.24M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $3.79M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $4.95M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $5.67M 10-K · filed 2019-02-28 |
| 2017-09-30 | $1.89M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $3.25M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $4.25M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $4.75M 10-K · filed 2018-03-15 |
| 2016-09-30 | $2.19M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $4.06M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $4.11M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $3.81M 10-K · filed 2017-03-16 |
| 2015-09-30 | $4.57M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $4.47M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $6.96M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $6.29M 10-K · filed 2016-03-15 |
| 2014-09-30 | $2.10M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $3.46M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $3.27M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $1.74M 10-K · filed 2015-03-13 |
| 2013-09-30 | $1.75M 10-Q/A · filed 2013-12-23 |
| 2012-12-31 | $1.08M 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |